drugset / Trial / NCT04575519

Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis

NCT04575519

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of 2 repurposed drugs (acetylsalicylic acid and ibuprofen), for use as adjunct therapy added to, and compared with, the standard of care (SoC) WHO-recommended TB regimen in drug-sensitive (DS) and multi-drug resistant (MDR) TB patients.

Timeline

Start
2021-03-04
Primary completion
2023-12-19
Completion
2024-03-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 300 mg
Subject Ibuprofen Small molecule 400 mg